Hartline Investment Corp’s AbbVie ABBV Stock Holding History

Hartline Investment Corp’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.68M	Hold	12,311	–	–	0.29%	43
2025 Q4	$2.81M	Buy	12,311 +23	+0.2%	+$5.24K	0.3%	41
2025 Q3	$2.85M	Buy	12,288 +2,462	+25%	+$501K	0.3%	49
2025 Q2	$1.82M	Buy	9,826 +1,128	+13%	+$210K	0.21%	56
2025 Q1	$1.82M	Sell	8,698 -69	-0.8%	-$13.4K	0.24%	47
2024 Q4	$1.56M	Sell	8,767 -48	-0.5%	-$8.82K	0.18%	55
2024 Q3	$1.74M	Hold	8,815	–	–	0.22%	49
2024 Q2	$1.51M	Sell	8,815 -1,702	-16%	-$282K	0.2%	48
2024 Q1	$1.92M	Buy	10,517 +1,245	+13%	+$215K	0.34%	68
2023 Q4	$1.44M	Hold	9,272	–	–	0.23%	47
2023 Q3	$1.38M	Hold	9,272	–	–	0.25%	49
2023 Q2	$1.25M	Buy	9,272 +15	+0.2%	+$2.2K	0.21%	56
2023 Q1	$1.48M	Sell	9,257 -516	-5%	-$78.9K	0.29%	48
2022 Q4	$1.58M	Buy	9,773 +6,915	+242%	+$1.06M	0.36%	47
2022 Q3	$384K	Sell	2,858 -6,572	-70%	-$943K	0.32%	78
2022 Q2	$1.01M	Sell	9,430 -332	-3%	-$50.7K	0.14%	68
2022 Q1	$1.1M	Sell	9,762 -6	-0.1%	-$872	0.14%	74
2021 Q4	$1.32M	Buy	9,768 +101	+1%	+$11.9K	0.18%	68
2021 Q3	$1.04M	Sell	9,667 -95	-1%	-$10.9K	0.15%	75
2021 Q2	$1.1M	Buy	9,762 +71	+0.7%	+$8K	0.14%	74
2021 Q1	$1.05M	Buy	9,691 +261	+3%	+$27.9K	0.16%	71
2020 Q4	$1.01M	Buy	9,430 +60	+0.6%	+$5.77K	0.14%	68
2020 Q3	$821K	Sell	9,370 -220	-2%	-$20.7K	0.14%	68
2020 Q2	$942K	Buy	9,590 +139	+1%	+$12.2K	0.2%	62
2020 Q1	$720K	Buy	9,451 +351	+4%	+$29.9K	0.18%	65
2019 Q4	$806K	Sell	9,100 -100	-1%	-$8.3K	0.17%	76
2019 Q3	$697K	Buy	9,200 +66	+0.7%	+$4.53K	0.17%	79
2019 Q2	$664K	Sell	9,134 -296	-3%	-$23.3K	0.16%	81
2019 Q1	$760K	Sell	9,430 -175	-2%	-$14.3K	0.2%	73
2018 Q4	$885K	Buy	9,605 +70	+0.7%	+$6.16K	0.27%	65
2018 Q3	$902K	Buy	9,535 +179	+2%	+$17K	0.21%	70
2018 Q2	$867K	Buy	9,356 +927	+11%	+$90.5K	0.23%	68
2018 Q1	$798K	Sell	8,429 -140	-2%	-$15.4K	0.22%	70
2017 Q4	$829K	Sell	8,569 -206	-2%	-$19.4K	0.23%	72
2017 Q3	$780K	Buy	8,775 +160	+2%	+$12.2K	0.24%	70
2017 Q2	$625K	Sell	8,615 -19,960	-70%	-$1.34M	0.2%	79
2017 Q1	$1.86M	Sell	28,575 -1,335	-4%	-$83.9K	0.6%	44
2016 Q4	$1.87M	Sell	29,910 -795	-3%	-$48.5K	0.65%	38
2016 Q3	$1.94M	Buy	30,705 +2,520	+9%	+$163K	0.7%	39
2016 Q2	$1.75M	Sell	28,185 -1,475	-5%	-$89.9K	0.63%	43
2016 Q1	$1.69M	Buy	29,660 +711	+2%	+$39.6K	0.62%	43
2015 Q4	$1.72M	Hold	28,949	–	–	0.64%	39
2015 Q3	$1.57M	Buy	28,949 +1,125	+4%	+$73.2K	0.57%	42
2015 Q2	$1.87M	Buy	27,824 +930	+3%	+$60.7K	0.62%	49
2015 Q1	$1.57M	Sell	26,894 -1,690	-6%	-$102K	0.51%	48
2014 Q4	$1.87M	Sell	28,584 -1,090	-4%	-$68.7K	0.63%	47
2014 Q3	$1.71M	Sell	29,674 -2,760	-9%	-$153K	0.62%	48
2014 Q2	$1.83M	Sell	32,434 -19,125	-37%	-$1M	0.66%	49
2014 Q1	$2.65M	Sell	51,559 -2,200	-4%	-$111K	0.91%	42
2013 Q4	$2.84M	Sell	53,759 -3,060	-5%	-$150K	0.99%	42
2013 Q3	$2.54M	Sell	56,819 -1,550	-3%	-$68.7K	0.99%	41
2013 Q2	$2.41M	Buy	+58,369	New	+$2.55M	0.97%	40

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hartline Investment Corp's ABBV Position: Q1 2026 in Review

Hartline Investment Corp held its AbbVie (ABBV) position steady in Q1 2026 at 12,311 shares worth $2.68M. The position accounts for 0.29% of the portfolio, ranked #43.

Hartline Investment Corp first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.85M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Hartline Investment Corp held 12,311 shares of AbbVie worth $2.68M as of Q1 2026.
Hartline Investment Corp left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.29% of Hartline Investment Corp's portfolio in Q1 2026, its #43 holding.
Hartline Investment Corp first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Hartline Investment Corp's AbbVie position peaked at $2.85M in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Hartline Investment Corp's 13F filing for Q1 2026, filed 29 Apr 2026.